Minimally Invasive Surgery Market is Expected to Exceed USD 50.60 billion in 2019.


A recent study by Transparency Market Research (TMR) forecasts that the global minimally invasive surgery market will grow at a CAGR of 10.5% between 2013 and 2019. TMR a market intelligence firm based in the United States, in its report states that the global minimally invasive surgery market, which was valued at US$25.03 billion in 2012, will reach a worth of US$50.60 billion by 2019. The report titled ‘Minimally Invasive Surgery Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019’ is available for sale on the website. Factors such as rising per capita expenditure on healthcare, technological developments, and a growing global geriatric population stimulate the global minimally invasive surgery market. Greater preference for minimally invasive procedures and rising incidence of target diseases such as cancer also drive the market for minimally invasive surgery. The preference for minimally invasive procedures over the conventional surgical procedures can be attributed to the benefits of the former type which includes low degree of patient trauma, quick recovery time, and a lesser duration of hospital stays.


The global minimally invasive surgery market is segmented on the basis of type of device, type of surgery, and geography. Based on device type, this market is categorized into surgical devices, monitoring and visualization devices, and endoscopy devices. In 2012, the segment for surgical devices held the dominant position in the minimally invasive surgery market. The market for surgical devices is anticipated to witness robust growth during the forecast period owing to widespread utilization of these devices in minimally invasive surgeries. On the basis of type of surgery, the minimally invasive surgery market is segmented into urological, cardiac, gastrointestinal, bariatric, gynecological, thoracic, vascular, breast, cosmetic, and orthopedic surgeries. Owing to rising income levels and high demand for cosmetic surgeries, the segment for cosmetic surgeries is expected to expand substantially in the forecasting horizon.

From the regional perspective, the global minimally invasive surgery market is segmented into Europe, North America, Asia Pacific, and Rest of the World. In 2012, North America held the dominant position in the overall minimally invasive surgery market. The growth of this market can be attributed to a well-defined reimbursement policy, the presence of a large pool of key manufacturers, and a large patient population. However, between 2013 and 2019, the Asia Pacific minimally invasive surgery market will record highest rate of growth because of the growth of the medical tourism industry in countries such as Thailand and India. Some of the prominent companies operating in the global minimally invasive surgery market include Varian Medical Systems Inc., Teleflex Inc., Stryker Corporation, Siemens Healthcare, NuVasive Inc., and Given Imaging Ltd.


The presence of a large patient pool in most developing economies is anticipated to create several opportunities for growth of the global minimally invasive surgery market in the near future. Lack of reimbursement, high costs of minimally invasive surgeries, and the imposition of excise duty on the sale of medical devices in the American market will hamper the growth of the global minimally invasive surgery market in the years to come.

Comments

Post a Comment

Popular posts from this blog

Head Guards Market is Expected to Witness a Steady Growth by 2028

Market Overview Safety equipment plays an important role in protecting sports enthusiasts from various injuries. Head guard is the key protection equipment widely used in games like boxing, baseball and rugby. This equipment has gained traction among athletes from amateur to professional players in both, national and international competitions. Rising number of national and international sports competitions globally, the demand for head guards has surged, which will in turn increase the volume of head guard sells from retail outlets to the company online sales channel. Many sports associations such as World Rugby, International Baseball Federation and World Boxing Association have necessitated the use of head guards for players in sports matches. In baseball alone, there are over 35 million players at different levels, and the U.S. houses close to 14 million amateur and professional players. This massive number of participants in baseball creates a significant customer base for h...
Read more

Die Cut Box Market to Witness an Outstanding Growth by 2028

Die Cut Box Marke t: Overview Die cut box is an innovative packaging solution for multiple end-use sectors. Growing need for fast moving consumer goods, ingenious packaging formats from design, and size perspective,  die cut box continues to offer an advantageous edge in product positioning. Die cut box allows the leading brands and manufacturers to integrate novel design elements, which in turn assures a higher threshold of customer acquisition viz.a.viz. effective branding and marketing. Besides industry specific drivers and trends, macroeconomic factors will also continue to influence demand for the die cut box across industries. Such factor include but aren’t limited to per capita disposable income, food retail sector growth, modern retail establishment growth etc. Outpacing growth in the e-commerce sector has gained traction for the corrugated packaging industry. Die cut box cost wouldn’t be a big burn to the pocket of die cut box manufacturers despite the re-usability of ...
Read more

Gynaecological Cancer Drugs Market Accounting US$ 41,855.8 million by 2026

The new report by Persistence Market Research (PMR) expects the global gynaecological cancer drugs market to witness significant growth, registering 6.2% CAGR during the forecast period. The global gynaecological cancer drugs market is also expected to bring in US$ 41,855.8 million revenue by the end of 2026. Treatment of cancer is being increasingly focused on be leading pharmaceutical companies, researchers, healthcare institutes and governments of various countries. With increasing number of research and development activities in cancer treatment, especially in gynaecological cancer treatment, new treatments are reaching an increasing number of physicians faster than ever. Also, availability of advanced treatment options and drugs has resulted in the decline in cancer mortality rate across major developed countries. However, the scenario is not same in the developing nations. This is due to the high cost of cancer treatment and lack of availability of new treatments. Gynaecologi...
Read more